全球智慧藥丸市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計智慧藥丸市場將從 2025 年的 26.6 億美元成長到 2034 年的 73.7 億美元，2026 年至 2034 年的複合年成長率為 11.97%。

隨著數位醫療技術的進步，全球智慧藥丸市場正蓬勃發展。智慧藥丸是一種可吞服的電子設備，能夠監測人體內部健康狀況、拍攝消化道影像並將資料傳送給醫療專業人員。這些設備正被擴大用於診斷消化系統疾病，為傳統醫療程序提供了一種微創替代方案。

多種因素正在推動智慧藥丸市場的成長。主要促進因素包括胃腸道疾病盛行率的上升以及對微創診斷技術日益成長的需求。微型感測器、無線通訊系統和醫學影像技術的進步正在提升智慧藥丸的功能和準確性。此外，人們對遠端患者監護和數位健康解決方案的日益關注也促使醫療專業人員採用這些創新診斷工具。

隨著數位化和互聯醫療技術在醫療保健系統中的日益普及，智慧藥丸市場被認為具有極其廣闊的發展前景。目前的研究和開發工作主要集中在提升口服型感測器的功能，例如藥物傳輸監測和即時健康追蹤。隨著醫療專業人員尋求更有效率的診斷解決方案，智慧藥丸有望在現代醫療保健中發揮日益重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球智慧藥丸市場：按應用分類

• 市場分析、洞察與預測
• 膠囊內視鏡
• 藥物輸送
• 生命徵象監測

第5章：全球智慧藥丸市場：依疾病分類

• 市場分析、洞察與預測
• 消化道出血
• 克隆氏症
• 小腸腫瘤
• 乳糜瀉
• 遺傳性息肉症候群
• 神經系統疾病
• 其他

第6章：全球智慧藥丸市場：依目標區域分類

• 市場分析、洞察與預測
• 食道
• 小腸
• 冒號
• 胃

第7章：全球智慧藥丸市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診設施

第8章 全球智慧藥丸市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • Otsuka Holdings Co. Ltd
  • Olympus Corporation
  • CapsoCam Plus
  • Pentax Medical
  • JINSHAN Science & Technology（Group）Co. Ltd
  • Check-Cap Ltd
  • EtectRx
  • Intromedic
  • Shenzen Jifu Medical Technology Co. Ltd
  • BodyCapUSA

The Smart Pill Market size is expected to reach USD 7.37 Billion in 2034 from USD 2.66 Billion (2025) growing at a CAGR of 11.97% during 2026-2034.

The global smart pill market is gaining momentum as digital healthcare technologies continue to advance. Smart pills are ingestible electronic devices that can monitor internal health conditions, capture images of the gastrointestinal tract, and transmit data to healthcare providers. These devices are increasingly used for diagnostic purposes, particularly in gastrointestinal disorders, offering a less invasive alternative to traditional medical procedures.

Several factors are driving the growth of the smart pill market. Increasing prevalence of digestive diseases and the rising demand for minimally invasive diagnostic techniques are key contributors. Technological advancements in miniaturized sensors, wireless communication systems, and medical imaging technologies are improving the functionality and accuracy of smart pills. In addition, growing interest in remote patient monitoring and digital health solutions is encouraging healthcare providers to adopt these innovative diagnostic tools.

The future prospects of the smart pill market appear highly promising as healthcare systems increasingly adopt digital and connected medical technologies. Ongoing research and development efforts are focused on enhancing the capabilities of ingestible sensors, including drug delivery monitoring and real-time health tracking. As healthcare providers seek more efficient diagnostic solutions, smart pills are expected to play an increasingly important role in modern medical practice.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Capsule Endoscopy
• Drug Delivery
• Vital Sign Monitoring

By Disease Identification

• Occult GI Bleeding
• Crohn's Disease
• Small Bowel Tumors
• Celiac Disease
• Inherited Polyposis Syndromes
• Neurological Disorders
• Others

By Target Area

• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By End-use

• Hospitals
• Outpatient Facilities

COMPANIES PROFILED

• Medtronic, Otsuka Holdings Co Ltd, Olympus Corporation, CapsoCam Plus, Pentax Medical, JINSHAN Science Technology Group Co Ltd, CheckCap Ltd, etectRx, Intromedic, Shenzen Jifu Medical Technology Co Ltd, BodyCapUSA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMART PILL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Capsule Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Vital Sign Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMART PILL MARKET: BY DISEASE IDENTIFICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Identification
• 5.2. Occult GI Bleeding Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Crohn's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Small Bowel Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Celiac Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Inherited Polyposis Syndromes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMART PILL MARKET: BY TARGET AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Target Area
• 6.2. Esophagus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Small Intestine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Large Intestine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Stomach Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMART PILL MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SMART PILL MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application
  • 8.2.2 By Disease Identification
  • 8.2.3 By Target Area
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application
  • 8.3.2 By Disease Identification
  • 8.3.3 By Target Area
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application
  • 8.4.2 By Disease Identification
  • 8.4.3 By Target Area
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application
  • 8.5.2 By Disease Identification
  • 8.5.3 By Target Area
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application
  • 8.6.2 By Disease Identification
  • 8.6.3 By Target Area
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SMART PILL INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic
  • 10.2.2 Otsuka Holdings Co. Ltd
  • 10.2.3 Olympus Corporation
  • 10.2.4 CapsoCam Plus
  • 10.2.5 Pentax Medical
  • 10.2.6 JINSHAN Science & Technology (Group) Co. Ltd
  • 10.2.7 Check-Cap Ltd
  • 10.2.8 EtectRx
  • 10.2.9 Intromedic
  • 10.2.10 Shenzen Jifu Medical Technology Co. Ltd
  • 10.2.11 BodyCapUSA